Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Bowen, DT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 27 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tauro, S; Hepburn, MD; Bowen, DT; Pippard, MJ
      Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes

      HAEMATOLOGICA
    2. Bowen, DT; Hellstrom-Lindberg, E
      Best supportive care for the anaemia of myelodysplasia: inclusion of recombinant erythropoietin therapy?

      LEUKEMIA RESEARCH
    3. Kottaridis, PD; Gale, RE; Frew, ME; Harrison, G; Langabeer, SE; Belton, AA; Walker, H; Wheatley, K; Bowen, DT; Burnett, AK; Goldstone, AH; Linch, DC
      The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogeneticrisk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials

      BLOOD
    4. Kerr, R; Cunningham, J; Bowen, DT
      Low-dose melphalan in elderly acute myeloid leukaemia: complete remissionsbut resistant relapse with therapy-related karyotypes

      LEUKEMIA
    5. Wang, LH; Groves, MJ; Hepburn, MD; Bowen, DT
      Glutathione S-transferase enzyme expression in hematopoietic cell lines implies a differential protective role for T1 and A1 isoenzymes in erythroid and for M1 in lymphoid lineages

      HAEMATOLOGICA
    6. Bowen, DT
      Oxidative stress and the myelodysplastic syndromes

      LEUKEMIA RESEARCH
    7. Gelly, KJ; Kerr, R; Rawlinson, S; Norris, A; Bowen, DT
      Transfusion-associated graft vs. host disease in a patient with high-gradeB-cell lymphoma. Should cellular products for patients with non-Hodgkin's lymphoma be irradiated?

      BRITISH JOURNAL OF HAEMATOLOGY
    8. West, RR; Stafford, DA; White, AD; Bowen, DT; Padua, RA
      Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure

      BLOOD
    9. Tauro, S; Bowen, DT
      In vitro development of haemopoietic progenitors in myelodysplastic syndromes (MDS)

      LEUKEMIA
    10. Gowans, ID; Hepburn, MD; Clark, DM; Patterson, G; Rawlinson, PSM; Bowen, DT
      The role of the Sysmex SE9000 immature myeloid index and Sysmex R2000 reticulocyte parameters in optimizing the timing of peripheral blood stem cell harvesting in patients with lymphoma and myeloma

      CLINICAL AND LABORATORY HAEMATOLOGY
    11. AUL C; BOWEN DT; YOSHIDA Y
      PATHOGENESIS, ETIOLOGY AND EPIDEMIOLOGY OF MYELODYSPLASTIC SYNDROMES

      Haematologica
    12. GALLAGHER AP; BURNETT AK; BOWEN DT; DARLEY RL
      MUTANT RAS SELECTIVELY PROMOTES SENSITIVITY OF MYELOID-LEUKEMIA CELLSTO APOPTOSIS BY A PROTEIN-KINASE C-DEPENDENT PROCESS

      Cancer research
    13. BOWEN DT; GELLY K; HEPBURN M; KANZ L; BRUGGER W; DENZLINGER C; CULLIGAN D
      LOW RESPONSE RATE TO A CONTINUOUS SCHEDULE OF AMIFOSTINE FOR LOW-RISKMYELODYSPLASTIC PATIENTS

      British Journal of Haematology
    14. DARLEY RL; GALLAGHER AP; BOWEN DT; BURNETT AK
      SYNERGY OF ATRA AND MUTANT RAS IN INDUCTION OF APOPTOSIS AND DIFFERENTIATION IN MYELOID-LEUKEMIA CELLS

      British Journal of Haematology
    15. GOWANS ID; HEPBURN MD; CLARK DM; PATTERSON G; RAWLINSON PSM; BOWEN DT
      THE SYSMEX SE9000 IMMATURE MYELOID INDEX AND R2000 RETICULOCYTE PARAMETERS TO OPTIMIZE TIMING OF STEM-CELL HARVEST

      British Journal of Haematology
    16. Bowen, DT; Denzlinger, C; Brugger, W; Culligan, D; Gelly, K; Adlakha, S; Groves, M; Hepburn, M; Kanz, L
      Poor response rate to a continuous schedule of Amifostine therapy for 'low/intermediate risk' myelodysplastic patients

      BRITISH JOURNAL OF HAEMATOLOGY
    17. TAURO S; HEPBURN MD; PEDDIE CM; BOWEN DT; PIPPARD MJ
      FUNCTIONAL DISTURBANCE OF MARROW MICROENVIRONMENT IN MYELODYSPLASTIC SYNDROMES

      Experimental hematology
    18. TAURO S; HEPBURN MD; BOWEN DT; PIPPARD MJ
      USE OF SHORT-TERM SUSPENSION-CULTURES TO IDENTIFY FUNCTIONAL ABNORMALITIES WITHIN THE MARROW MICROENVIRONMENT IN MYELODYSPLASTIC SYNDROMES (MDS) AND PATIENTS HARVESTED FOR BONE-MARROW TRANSPLANTATION

      Experimental hematology
    19. PEDDIE CM; WOLF CR; MCLELLAN LI; COLLINS AR; BOWEN DT
      OXIDATIVE DNA-DAMAGE IN CD34(-NECROSIS-FACTOR-ALPHA CONCENTRATION() MYELODYSPLASTIC CELLS IS ASSOCIATED WITH INTRACELLULAR REDOX CHANGES AND ELEVATED PLASMA TUMOR)

      British Journal of Haematology
    20. TAURO S; HEPBURN MD; BOWEN DT; PIPPARD MJ
      REGULATION OF STROMAL FUNCTION BY HEMATOPOIETIC-CELLS

      Blood
    21. DARLEY RL; GALLAGHER AP; BOWEN DT; BURNETT AK
      MUTANT RAS SELECTIVELY PROMOTES SENSITIVITY OF MYELOID-LEUKEMIA CELLSTO APOPTOSIS BY A PKC-DEPENDENT PROCESS

      Blood
    22. BOWEN DT; PEDDIE CM; COLLINS AR; WOLF CR
      PYRIMIDINE NUCLEOTIDE OXIDATION IN CD34-NECROSIS-FACTOR-ALPHA( MYELODYSPLASTIC CELLS IS ASSOCIATED WITH ALTERED INTRACELLULAR REDOX AND ELEVATED PLASMA TUMOR)

      Blood
    23. PEDDIE CM; COLLINS AR; WOLF CR; BOWEN DT
      DNA-DAMAGE IN FRESHLY ISOLATED BONE-MARROW CD34+ CELLS ASSOCIATED WITH OXIDATIVE STRESS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

      Blood
    24. CULLIGAN DJ; BOWEN DT; MAY A; WHITE D; PADUA RA; BURNETT AK
      REFRACTORY-ANEMIA WITH PRELEUKAEMIC POLYCLONAL HEMATOPOIESIS AND THE EMERGENCE OF MONOCLONAL ERYTHROPOIESIS ON DISEASE PROGRESSION

      British Journal of Haematology
    25. BOWEN DT; CULLIGAN D; BEGUIN Y; KENDALL R; WILLIS N
      ESTIMATION OF EFFECTIVE AND TOTAL ERYTHROPOIESIS IN MYELODYSPLASIA USING SERUM TRANSFERRIN RECEPTOR AND ERYTHROPOIETIN CONCENTRATIONS, WITHAUTOMATED RETICULOCYTE PARAMETERS

      Leukemia
    26. BOWEN DT; PADUA RA; BURNETT AK; DECASTRO CM; KAUFMAN RE
      2 NEW POLYMORPHISMS BUT NO MUTATIONS OF THE KIT GENE IN PATIENTS WITHMYELODYSPLASIA AT POSITIONS CORRESPONDING TO HUMAN FMS AND MURINE W LOCUS MUTATIONAL HOT-SPOTS

      Leukemia
    27. TENNANT GB; ALSABAH AI; CULLIGAN D; BOWEN DT; JACOBS A; BURNETT AK
      IN-VITRO RESPONSE OF MYELOID PROGENITORS TO PHYTOHAEMAGGLUTIN AND INTERLEUKIN-2 IS RELATED TO SURVIVAL OF SOME MYELODYSPLASTIC PATIENTS

      Experimental hematology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/08/20 alle ore 15:59:27